Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

360 DigiTech Announced Offering of. 5,540,000 Class A Ordinary Shares in 424B5 Filing

https://www.sec.gov/Archives/edgar/data/1741530/000110465922119761/tm2228449-6_424b5.htm
byCharles Gross
November 17, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

https://www.sec.gov/Archives/edgar/data/1741530/000110465922119761/tm2228449-6_424b5.htm

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

AstraZeneca Announced Ultomiris Recommended For NMOSD EU Approval

By Charles Gross
April 3, 4:38 AM
Ultomiris (ravulizumab) has been recommended for marketing authorisation in the European Union (EU) for the treatment of adult patients with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive (Ab+). If authorised, Ultomiris would be the first and only approved long-acting C5 complement inhibitor for the treatment of AQP4 Ab+ NMOSD in the EU.

AZN